HHS HIV Challenge Encourages Community Engagement to Reduce HIV-Related Stigma and Disparities
The negative stigma surrounding HIV can affect patients’ emotional well-being and mental health, and the stigma can come from anywhere: healthcare professionals, communities, and even themselves. In partnership with the Office of the Assistant Secretary of Health and Office of Infectious Disease and HIV/AIDS Policy, the U.S. Department of Health and Human Services (HHS) Office of Minority Health created the HIV Challenge, a community engagement program to reduce HIV-related stigma and disparities by “providing an opportunity for individuals and organizations to participate in developing novel innovative approaches that can be successfully implemented within their local communities.”
The Case of the Transgender Considerations for Cancer Screening
Sally, a nurse practitioner in a cancer survivorship clinic, is preparing to discuss screening and surveillance guidelines with Jonah, a 32-year-old survivor of Hodgkin lymphoma. Sally reviews Jonah’s patient history form and notes that Jonah uses he and him pronouns. His gender identity is male and sex assigned at birth was female. Jonah’s surgical history includes gender-affirming surgery on chest tissue (also known as top surgery), and his current medications include supplemental testosterone. Jonah also specifies that he is transmasculine—an umbrella term used to indicate that Jonah feels a connection with masculinity.
HHS Releases National Strategic Plan to End HIV Epidemic
The two most recent administrations prioritized ending the HIV epidemic, which has claimed the lives of more than 700,000 Americans since the virus was first identified in the 1980s. To follow those initial efforts, the U.S. Department of Health and Human Services (HHS) released a strategic roadmap to end the HIV epidemic and reduce new HIV infections by 90% by 2030.
Sex Is an Important Dimension of Cancer Psychosocial Care That We Need to Stop Neglecting
My charge nurse approached me and told me that I am getting an admission from the emergency department who presented with high blood pressure and shortness of breath. She told me that the patient is on concurrent chemoradiation therapy and has a rectal cancer.
Get Comfortable Talking to Patients About Sexuality During and After Cancer Treatment
Bothersome and distressing sexual dysfunction is common in both men and women living with cancer. Treatments can potentially alter a person’s sexual health in the physical, emotional, mental ,and social well-being realms of care. Literature has shown that time constraints and level of comfort with sexual health content are barriers to addressing patients’ sexual health concerns. On Friday, April 12, 2019, at the ONS 44th Annual Congress in Anaheim, CA, speakers provided an overview of sexual health concerns and strategies to assure a positive and respectful approach to female and male patients with cancer who are experiencing them.
Sexual Function Varies by Some Treatments in Breast Cancer Survivors
Surgical modality and receipt of chemotherapy or radiotherapy are not associated with sexual function, as measured by the Female Sexual Function Index (FSFI). Patients receiving endocrine therapy with an aromatase inhibitor had significantly lower sexual function scores than those who received no endocrine therapy or those on tamoxifen, said a group of U.S. researchers who presented their findings during a poster session on Saturday, December 10, at the San Antonio Breast Cancer Symposium.